​
​

Cyclacel Pharmaceuticals Ownership | Who Owns Cyclacel Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Cyclacel Pharmaceuticals Ownership Summary

Cyclacel Pharmaceuticals is owned by 9.04% institutional investors, and 90.96% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.42% of its assets in Cyclacel Pharmaceuticals shares.

CYCC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCyclacel Pharmaceuticals9.04%-90.96%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202320-13.04%1,134,910-45.03%93.34%620.00%5-
Jun 30, 202323-11.54%2,064,450-17.83%164.10%5-16.67%5-28.57%
Mar 31, 202326-13.33%2,512,5182.28%204.21%6-57.14%7-
Dec 31, 20223015.38%2,456,5915.48%216.10%14-22.22%775.00%
Sep 30, 20222613.04%2,328,97510.51%184.37%1838.46%4-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index9.13K0.42%2.40K
Vanguard Institutional Extnd Mkt Idx Tr5.80K0.27%-
Fidelity Nasdaq Composite Index709.000.03%-
NT Ext Equity Mkt Idx Fd - NL572.000.03%-
Fidelity Series Total Market Index567.000.03%-
NT Ext Equity Mkt Idx Fd - DC - NL - T2461.000.02%1.00
NT Ext Equity Mkt Idx Fd - L380.000.02%-
Northern Trust Extended Eq Market Idx380.000.02%-
Spartan Total Market Index Pool E194.000.01%-
NT Ext Eq Mkt Indx Fd DC Lending Tier 559.000.00%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 21, 2023McBarron Paul See RemarksBuy$6.02K
Dec 21, 2023McBarron Paul See RemarksBuy$6.25K
Dec 21, 2023Rombotis Spiro George President and CEOBuy$20.12K
Dec 21, 2023Rombotis Spiro George President and CEOBuy$19.36K
Nov 30, 2021BARKER SAM L-Sell$42.86

Insider Transactions Trends

DateBuySell
2024 Q1--
2023 Q48-
2023 Q2--
2023 Q1--
2022 Q2--

CYCC Ownership FAQ

Who Owns Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals shareholders are primarily institutional investors at 9.04%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Cyclacel Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which Cyclacel Pharmaceuticals falls below.

Does Blackrock own Cyclacel Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Cyclacel Pharmaceuticals.

Who is the top mutual fund holder of Cyclacel Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of Cyclacel Pharmaceuticals shares, with 0.42% of its total shares outstanding invested in 9.13K Cyclacel Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools